Skip to main content

Drug Interactions between Nimbex and ranitidine bismuth citrate

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Minor

cisatracurium raNITIdine bismuth citrate

Applies to: Nimbex (cisatracurium) and ranitidine bismuth citrate

Ranitidine may or may not decrease the effectiveness of neuromuscular blocking agents. The mechanism is unknown. Data have been conflicting and causality has not been clearly determined due to the presence of other drugs. Until more information is available, the clinician should be aware of the possibility of an interaction.

References (3)
  1. Woodworth GE, Sears DH, Grove TM, et al. (1989) "The effect of cimetidine and ranitidine on the duration of action of succinylcholine." Anesth Analg, 68, p. 295-7
  2. McCarthy G, Mirakhur RK, Elliott P, Wright J (1991) "Effect of H2-receptor antagonist pretreatment on vecuronium- and atracurium-induced neuromuscular block." Br J Anaesth, 66, p. 713-5
  3. Katende RS, Dimich I (1987) "Resistance to nondepolarizing muscle relaxants in a patient treated with ranitidine." Mt Sinai J Med, 54, p. 330-1

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer